Bryan, Garnier & Co's News

Sanofi: For sure the new CETP inhibitor’s failure is good news for PCSK9s and so for Sanofi

BUY, Fair Value EUR103 (+18%)
News published on
October Tuesday 13, 2015



For more information, please contact marketing@bryangarnier.com